‘Excellent outcome’: New diabetic CKD drug option for GPs
Monitor serum potassium a month after patients start finerenone, recommends a leading nephrologist.
GPs can now prescribe finerenone under the PBS to prevent worsening kidney function in adults with chronic kidney disease caused by type 2 diabetes.
More than 26,000 patients with diabetic chronic kidney disease (CKD) who are still at risk of declining renal function despite first-line therapy are expected to benefit from the new listing, which went live on 1 July.
